FACET BIOTECH CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.00B

156 transactions

Summary

FACET BIOTECH CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.70BSales: $67.5M24 insiders

Date	Insider	Type	Value
2010-04-21	Joint reporting: ABBOTT LABORATORIES; Amber Acquisition Inc.	J	$161.5M
2010-04-21	Hasnain Faheem(President & CEO)	D	$8.1M
2010-04-21	Hasnain Faheem(President & CEO)	D	$2.8M
2010-04-21	Hasnain Faheem(President & CEO)	D	$2.2M
2010-04-21	GUGGENHIME ANDREW(SVP & CFO)	D	$1.7M
2010-04-21	GUGGENHIME ANDREW(SVP & CFO)	D	$1.2M
2010-04-21	GUGGENHIME ANDREW(SVP & CFO)	D	$866K
2010-04-21	Hora Maninder(VP, Prod Ops. & Quality)	D	$864K
2010-04-21	GUGGENHIME ANDREW(SVP & CFO)	D	$566K
2010-04-21	Goodwin Bradford S	D	$540K
2010-04-21	Hora Maninder(VP, Prod Ops. & Quality)	D	$455K
2010-04-21	Huh Hoyoung	D	$450K
2010-04-21	Hora Maninder(VP, Prod Ops. & Quality)	D	$432K
2010-04-21	CROSS HERB(VP of Finance)	D	$378K
2010-04-21	Hora Maninder(VP, Prod Ops. & Quality)	D	$373K
2010-04-21	CROSS HERB(VP of Finance)	D	$313K
2010-04-21	CROSS HERB(VP of Finance)	D	$189K
2010-04-21	CROSS HERB(VP of Finance)	D	$185K
2010-04-21	Goodwin Bradford S	D	$180K
2010-04-21	Goodwin Bradford S	D	$90K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

FACET BIOTECH CORP — Contributions, Lobbying & Contracts | Poliscope